CHANGES to immigration policy post-Brexit has resulted in a shortage of seasonal labour at UK-based medicinal cannabis cultivation sites, claims the company that owns...
A PERMANENT solution to the import impasse on children’s epilepsy cannabis medication has emerged with the Dutch manufacturer set to see the medicines made...
Prof Mike Barnes, one of the UK's leading cannabis clinicians responds to suggestions that the medicines for UK children with epilepsy can be sourced...
PRESS RELEASE
FRANKFURT-based medical cannabis holding company Bloomwell Group (“Bloomwell,” “Bloomwell Group,” or the “Company”) has closed a significant multi-million Euro funding...